Modulation of Platelet Aggregation Response by Factors Released from Polymorphonuclear Leukocytes

References

• Henry, R. L. (1965). Leukocytes and thrombosis. Thromb Diath Haemorrh, 13, 35–46.
   PubMedGoogle Scholar
• Marcus, A. J. (1983). Recent progress in the role of platelets in occlusive vascular disease. Stroke, 14, 475–479.
   PubMed Web of Science ®Google Scholar
• Marcus, A. J. (1990). Thrombosis and inflammation as multicellular process: pathophysiologic significance of transcellular metabolism. Blood, 66, 1093–1097.
   Google Scholar
• Cerletti, C., Evangelista V. and de Gaetano, G. (1992). Polymorphonuclear leukocyte-dependent modulation of platelet function: Relevance to the pathogenesis of thrombosis. Pharmacol Res, 26, 261–268.
   PubMed Web of Science ®Google Scholar
• Engler, R. L., Schmid-Schoenbein, G. W. and Pavla, R. (1983). Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Amer J Pathol, 111, 98–111.
   PubMed Web of Science ®Google Scholar
• Mehta, J. L., Lawson, D. L., Nichols, W. W. and Mehta, P. (1989). Modulation of vascular tone by neutrophils: Dependence on endothelial integrity. Amer J Physiol, 257, H1315–H1320.
   PubMed Web of Science ®Google Scholar
• Barnhart, M. I. (1968). Role of blood coagulation in acute inflammation. Biochem Pharmacol, 17 (Suppl): 205–219.
   Google Scholar
• Weksler, B. B. and Coupal, C. E. (1973). Platelet-dependent generation of chemotactic activity in serum, J Exp Med, 137, 1419–1430.
   PubMed Web of Science ®Google Scholar
• Spisani, S., Giuliani, A., Cavalleti, T., Zaccarini, M., Milani, L., Gavioli, R. and Traniello, S. (1992). Modulation of neutrophil functions by activated platelet release factors. Inflammation, 16, 149–157.
   Web of Science ®Google Scholar
• Del Maschio, A., Dejna, E. and Bazzoni, G. (1993). Bidirectional modulation of platelet and polymorphonuclear leukocytes activities. Ann Hematol, 67, 23–31.
   PubMed Web of Science ®Google Scholar
• Selby, C., Drost, E., Lannan, S., Wraith, P. K. and Macnee, W. (1991). Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease. Am Rev Resp Dis, 143, 1359–1364.
   PubMed Web of Science ®Google Scholar
• Bazzoni, G., Dejana, E. and Delmaschio, A. (1991). Platelet-neutrophil interactions-possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica, 76, 491–499.
   PubMed Web of Science ®Google Scholar
• Faint, R. W. (1992). Platelet-neutrophil interactions: Their significance. Blood Rev, 6, 83–91.
   PubMed Web of Science ®Google Scholar
• Stewart, B. J. (1993). Neutrophils and deep venous thrombosis. Haemostasis, 23, 127–140.
   PubMedGoogle Scholar
• Babior, B. M., Kipnes, R. S. and Curnutte, J. T. (1973). Biological defense mechanisms. The. production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest, 52, 421–444.
   Web of Science ®Google Scholar
• Homan-Muller, J. W. T., Weening, R. S. and Roos, D. (1975). Production of hydrogen peroxide by phagocytosing human granulocytes. J Lab Clin Med, 85, 198–207.
   PubMed Web of Science ®Google Scholar
• Tauber, A. I. and Babior, B. M. (1977). Evidence for hydroxyl radical production by human neutrophils. J Clin Invest, 60, 374–379.
   PubMed Web of Science ®Google Scholar
• Rosen, H. and Klebanoff, S. J. (1976). Chemiluminescence and superoxide radical production by myeloperoxidase deficient leukocytes. J Clin Invest, 58, 50–60.
   PubMed Web of Science ®Google Scholar
• Salvemini, D. and Botting, R. (1990). The effect of free radicals scavengers on platelet adhesion and aggregation. Drug News Perspectives, 13, 202–212.
   Google Scholar
• Salvemini, D., Radziszewski, W., Mollace, V., Moore, A., Willoughly, D. and Vane, J. R. (1991). Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation. Eur. J. Pharmacol., 199, 15–18.
   PubMed Web of Science ®Google Scholar
• Salvemini, D. and Botting, R. (1992). Modulation of platelet function by free radicals and free radical scavengers. Trends Pharmacol. Sci., 14, 36–42.
   Web of Science ®Google Scholar
• Handin, R. I., Karabin, R., Boxer, and G. J. (1977). Enhancement of platelet function by superoxide anion. J. Clin. Invest., 59, 959–965.
   PubMed Web of Science ®Google Scholar
• Salvemini, D., de Nucci, G., Sneddon, J. M., Vane, J. R. (1989). Superoxide anions enhance platelet adhesion and aggregation. Brit. J. Pharmacol., 97, 1145–1150.
   PubMed Web of Science ®Google Scholar
• Pratico, D., Luliano, L., Alessandri, C., Camterina, C., and Violi, F. (1993). Polymorphonuclear leukocyte-derived O2-reactive species activate primed platelets in human whole blood. Am. J. Physiol., 264 (Heart Circ Physiol) 33, H1582–H1587.
   PubMed Web of Science ®Google Scholar
• Hirafuji, M. and Shinoda, H. (1993). Roles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro. Brit. J. Pharmacol., 109, 524–529.
   PubMed Web of Science ®Google Scholar
• Renesto, P., Tahar, M. S. and Chingard, M. (1994). Modulation by superoxide anions of neutrophil-mediated platelet activation. Biochem. Pharmacol., 47, 1401–1404.
   PubMed Web of Science ®Google Scholar
• Rodivien, R., Lindon, J. N. and Levine, P. H. (1976). Physiology of blood platelet following exposure to hydrogen peroxide. Br. J. Haematol., 33, 19–26.
   PubMed Web of Science ®Google Scholar
• Del Principe, D., Menichelli, A., De Matteis, W., Di Corpo, M. L., Di Giulio, S. and Finazzi-Agro, A. (1985). Hydrogen peroxide has a role in aggregation of human platelets. FEBS Lett., 185, 142–146.
   PubMed Web of Science ®Google Scholar
• Ohyashiki, T., Kobayashi, M. and Matsui, K. (1991). Oxygen-radical-mediated lipid peroxidation and inhibition of ADP-induced platelet aggregation. Arch. Biochem. Biophys., 288, 282–286.
   PubMed Web of Science ®Google Scholar
• Stuart, M. J. and Holmsen, H. (1977). Hydrogen-peroxide, an inhibitor of platelet function—Effect on adenine nucleotide metabolism and release reaction. Am. J. Hematol., 2, 53–63.
   PubMed Web of Science ®Google Scholar
• Pratico, D., Luliano, L., Ghiselli, A., Alessandri, C. and Violi, F. (1991). Hydrogen peroxide as trigger of platelet aggregation. Haemostatis, 21, 169–174.
   PubMedGoogle Scholar
• Hecker, G., Utz, J., Kupferschmidt, R. J. and Ullrich, V. (1991). Low levels of hydrogen peroxide enhance platelet aggregation by cyclooxygenase activation. Eicosanoids, 4, 107–113.
   PubMedGoogle Scholar
• Pratico, D., Luliano, L., Pulcinelli, F. M., Bonavita, M. S., Gazzaniga, P. P. and Violi, F. (1992). Hydrogen peroxide triggers activation of human platelets selectively exposed to nonaggregating concentrations of arachidonic acid and collagen. J. Lab. Clin. Med., 119, 364–370.
   PubMed Web of Science ®Google Scholar
• Test, S. T. and Weiss, S. J. (1984). Quantitative and temporal characterization of the extracellular H2O2 pool generated by human neutrophils. J. Biol. Client., 259, 399–105.
   Web of Science ®Google Scholar
• Iuliano, L., Pratico, D., Bonavita, M. S., Violi, F. (1992). Involvement of phospholipase A2 in H2O2-dependent platelet activation. Platelets, 2, 87–90.
   Google Scholar
• Bosin, T. R. (1989). Oxidant stress stimulates active transport of serotonin by platelets. J. Pharmacol. Exp. Ther., 248, 67–72.
   PubMed Web of Science ®Google Scholar
• Canoso, R. T., Rodvien, R., Scoon, K., Levine, P. H. (1974). Hydrogen peroxide and platelet function. Blood, 43, 645–656.
   PubMed Web of Science ®Google Scholar
• Levine, P. H., Weinger, R. S., Simon, J., Scoon, K. L., Krinsky, N. I. (1976). Leukocyte platelet interaction. Release. of hydrogen peroxide by granulocytes as a modulator of platelet reactions. J. Clin. Invest., 57, 955–963.
   PubMed Web of Science ®Google Scholar
• Sumiya, T., Fujimoto, Y., Nishida, H., Morikawa, Y., Sakauma, S., Fujita, T. (1993). Effects of reactive oxygen species on arachidonic acid metabolism in rabbit platelets. Free Rad. Biol. Med., 15, 101–104.
   PubMed Web of Science ®Google Scholar
• Clark, R. A., Klebanoff, S. J. (1979). Myeloperoxidasemediated platelet release reaction. J. Clin. Invest., 63, 177–183.
   PubMed Web of Science ®Google Scholar
• Ambrasio, G., Golino, P, Pasucci, I., Rosolowsky, M., Campbell, W. B., DeClark, F., Tritto, I., Chariello, M. (1994). Modulation of platelet function by reactive oxygen metabolites. Amer. J. Physiol., 267 (Heart Circ Physiol.36): H308–H318.
   PubMed Web of Science ®Google Scholar
• Hashizume, T., Yamaguchi, H., Kawamoto, A., Tamura, A., Sato, T., Fuji, T. (1991). Lipid peroxide makes rabbit platelet hyperaggregable to agonists through phospholipase A2 activation. Arch. Biochem. Biophys., 289, 47–52.
   PubMed Web of Science ®Google Scholar
• Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., Freeman, B. A. (1990). Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci., 87, 1620–1624.
   PubMed Web of Science ®Google Scholar
• Rubanyi, G. M., Ho, E. H., Cantor, E. H., Lumma, W. C., Botelho, L. H. P. (1991). Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes. Biochem. Biophys. Res. Commun., 181, 1392–1397.
   PubMed Web of Science ®Google Scholar
• Clancy, R. M., Leszczynska-Piziak, J., Abramson, S. B. (1992). Nitric oxide an endothelial cell relaxation factor inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest, 90, 1116–1121.
   PubMed Web of Science ®Google Scholar
• Seth, R, Kumari, R., Dikshit, M., Srimal, R. C. (1994). Effect of NO and arginine on rat polymorphonuclear leukocytes. Can. J. Physiol. Pharmacol., 72, (Suppl 1): 477.
   Google Scholar
• Seth, R, Kumari, R., Dikshit, M., Srimal, R. C. (1994). Modulation of rat peripheral polymorphonuclear leukocyte response by nitric oxide and arginine. Blood, 84, 2741–2748.
   PubMed Web of Science ®Google Scholar
• Alexandere, A., Doni, M. G., Padoin, E., Deana, R. (1986). Inhibition by antioxidants of agonist evoked cytosolic calcium increase, ATP secretion and aggregation of aspirinated human platelets. Biochem. Biophys. Res. Commun., 139, 509–514.
   PubMed Web of Science ®Google Scholar
• Violi, F., Ghiselli, A., Iuliano, L., Alessandri, C., Cordova, C., Balsano, F. (1988). Influence of hydroxyl radicals on platelet function. Haemostasis, 18, 91–98.
   PubMedGoogle Scholar
• Iuliano, L., Pedersen, J. Z., Pratico, D., Rotilio, G. and Violi, F. (1994). Role of hydroxyl radicals in the activation of human platelets. Eur. J. Biochem., 221, 695–704.
   PubMedGoogle Scholar
• Marshall, L. A. and Roshak, A. (1993). Coexistence of two biochemically distinct phospholipase A2 activities in human platelet, monocyte, and neutrophil. Biochem. Cell. Biol., 71, 331–339.
   PubMed Web of Science ®Google Scholar
• Clark, R. A. and Klebanoff, S. J. (1980). Neutrophil-platelet interaction mediated by myeloperoxidase by hydrogen peroxide. J. Immunol., 124, 399–405.
   PubMed Web of Science ®Google Scholar
• Marwijk Kooy, M. van., Akkerman, J. W. N., Asbeck, S. van., Borghius, L. and Prooijen, H. C. van. (1993). UVB radiation exposes fibrinogen binding sites on platelets by activating protein kinase C via reactive oxygen species. Brit. J. Haematol., 83, 253–258.
   PubMed Web of Science ®Google Scholar
• Higgs, G. A., McCall, E. and Youlten, L. J. F. (1975). A chemotactic role for prostaglandins released from polymorphonuclear leukocytes during phagocytosis. Brit. J. Pharmacol., 53, 539–546.
   PubMed Web of Science ®Google Scholar
• Higgs, G. A., Bunting, S., Moncada, S. and Vane, J. R. (1976). Polymorphonuclear leukocytes produce thromboxane-A2-like activity during phagocytosis. Prostaglandins, 12, 749–757.
   PubMed Web of Science ®Google Scholar
• Evangelista, V., Rajtar, G., de Gaetano, G., White, J. G. and Cerletti, C. (1991). Platelet activation by FMLP-stimulated polymorphonuclear leukocytes: The activity of cathepsin G is not prevented by antiproteinase. Blood, 77, 2379–2388.
   PubMed Web of Science ®Google Scholar
• Maugeri, N., Evangelista, V., Piccardoni, P., Dell Elba, G., Celardo, A., de Gaetano, G. and Cerletti, C. (1992). Transcellular metabolism of arachidonic acid: Increased platelet thromboxane generation in the presence of activated polymorphonuclear leukocytes. Blood, 80, 447–451.
   PubMed Web of Science ®Google Scholar
• Hernandez, R., Alemany, M., Bozzo, J., Buchnan, M. R., Ordinas, A. and Bastida, E. (1993). Platelet adhesivity to subendothelium is influenced by polymorphonuclear leukocytes: Studies with aspirin and salicylate. Haemostasis, 23, 1–7.
   PubMedGoogle Scholar
• Buchanan, M. R., Butt, R. W. and Turpie, A. G. G. (1987). Effect of nafazatrom on platelet function and release: Relationship to symptomatic episodes in patients with peripheral vascular disease. Amer. Heart. J., 113, 1133–1137.
   PubMed Web of Science ®Google Scholar
• Borgeat, R, Hamberg, M. and Samuelsson, B. (1976). Transformation of arachidonic acid and homo—linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy. acids from novel lipoxygenases. J. Biol. Chem., 251, 7816–7820.
   PubMed Web of Science ®Google Scholar
• Samuelsson, B. (1983). Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science, 220, 568–575.
   PubMed Web of Science ®Google Scholar
• Maclouf, J., Fruteau de Laclos, B. and Borgeat, P. (1982). Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet-derived 12-hydroxyicosatetraenoic acid. Proc. Natl. Acad. Sci. USA, 79, 6042–6046.
   PubMed Web of Science ®Google Scholar
• Marcus, A. J., Brokeman, M. J., Safier, L. B., Ullman, H. L. and Islam, N. (1982). Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro. Biochem. Biophys. Res. Commun., 109, 130–137.
   PubMed Web of Science ®Google Scholar
• Jundi, T. W., Spycher, M. O., Nydegger, U. E. and Barandun, S. (1986). Platelet-leukocyte interactions: selective binding of thrombin stimulated platelets to human monocytes, polymorphonuclear leukocytes and related cell lines. Blood 67, 629–636.
   PubMed Web of Science ®Google Scholar
• Lindoren, J. A., Hansson, G. and Samuelsson, B. (1981). Formation of novel hydroxylated eicosatetraenoic acids in preparations of human polymorphonuclear leukocytes. FEBS Lett., 128, 329–335.
   PubMed Web of Science ®Google Scholar
• Borgeat, P., Fruteau de Laclos, B., Picard, S., Drapeau, J., Vallerland, P. and Corey, E. J. (1982). Studies on the mechanism of formation of the 5S, 12S-dihydroxy-6,8,10,14,(E,2,E,2)-icosatetraenoic acid in leukocytes. Prostaglandins, 23, 713–724.
   PubMedGoogle Scholar
• Antoine, C., Murphy, R. C., Henson, P. M. and Maclouf, J. (1992). Time-dependent utilization of platelet arachidonic acid by the neutrophil in formation of 5-lipoxygenase products in platelet-neutrophil co-incubations. Biochem. Biophys. Acta., 1128, 139–146.
   PubMed Web of Science ®Google Scholar
• Dahl, M-L. (1985). Aggregating and prostanoid-releasing effects of platelet-activating factor and leukotrienes on human polymorphonuclear leukocytes and platelets. Int. Arch. Allergy Appl. Immunol., 76, 145–150.
   PubMedGoogle Scholar
• Marcus, A. J., Safier, L. B., Ullman, H. L., Islam, N., Brokeman, M. J. and von Schacky, C. (1987). Studies of the mechanisms of w-hydroxylation of platelet 12-hydroxyecosatetraenoic acid (12-HETE) by unstimulated neutrophils. J. Clin. Invest., 79, 179–187.
   PubMed Web of Science ®Google Scholar
• Marcus, A. J., Safier, L. B., Ullman, H. L., Islam, N., Brokeman, M. J., Falck, J. R., Fischer, S. and von Schacky, C. (1988). Platelet-neutrophil interactions: (12S)-hydroxyeicosatetraen-l,20-dioic acid, a new eicosanoid synthesized by unstimulated neutrophils from (12S)-20-dihydroeicosatetraenoic acid. J. Biol. Chem., 263, 2223–2229.
   PubMed Web of Science ®Google Scholar
• McCulloch, R. K., Croft, K. D. and Vandongen, R. (1992). Enhancement of platelet 12-HETE production in the presence of polymorphonuclear leukocytes during calcium ionophore stimulation. Biochem. Biophys. Acta., 1133, 142–146.
   PubMed Web of Science ®Google Scholar
• Schattner, M. A., Geffner, J. R., Istruiz, M. A. and Lazzari, M. A. (1990). Inhibition of human platelet activation by polymorphonuclear leukocytes. Brit. J. Pharmacol., 101, 253–256.
   PubMed Web of Science ®Google Scholar
• Nicolini, F. A., Wilson, A. C., Mehta, P. and Mehta, J. L. (1990a). Comparative platelet inhibitory effects of human neutrophils and lymphocytes. J. Lab. Clin. Med., 116, 147–152.
   PubMed Web of Science ®Google Scholar
• Nicolini, F. A. and Mehta, J. L. (1990b). Inhibitory effect of unstimulated neutrophils on platelet aggregation by release of a factor similar to endothelium derived relaxing factor (EDRF). Biochem. Pharmacol., 40, 2265–2269.
   PubMed Web of Science ®Google Scholar
• Evangelista, V., Rajtar, G., Gaetano, G. D., White, J. G. and Cereletti, C. (1991). Platelet activation by fmlp-stimulated polymorphonuclear leukocytes. The. activity of cathepsin G is not prevented by antiproteinases. Blood, 77, 2379–2388.
   PubMed Web of Science ®Google Scholar
• Del Maschio, A., Evangelista, V. G., Ratar, G., Chen, C., Cerletti C. and De Gaetano, G. (1990). Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. Amer. J. Physiol., 258, H870–H879.
   PubMed Web of Science ®Google Scholar
• Valles, J., Santos, M. T., Marcus, A. J., Safier, L. B., Broekman, M. J., Islam, N., Ullman, H. L. and Aznar, J. (1993). Downregulation of human platelet reactivity by neutrophils: Participation of lipoxygenase derivatives and adhesive proteins. J. Clin. Invest., 92, 1357–1365.
   PubMed Web of Science ®Google Scholar
• Buchanan, M. R. and Bastida, E. (1988). Endothelium and underlying membrane reactivity with platelets, leukocytes and tumor cells: Regulation by the lipoxygenase-derived fatty acid metabolites, 13-HODE and HETES. Medical Hypotheses, 27, 317–325.
   PubMed Web of Science ®Google Scholar
• De Graaf, J. C., Bult, H., De Meyer, G. R. Y. and Sixma, J. J. (1989). Platelet adhesion to subendothelial structures under flow conditions: No effect of lipoxygenase product 13-HODE. Thromb. Haemostas., 62, 802–806.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick, F. A. and Murphy, R. C. (1988). Cytochrome P-450 metabolism of arachidonic acid formation and biological actions of epoxygenase derived eicosanoids. Pharmacol. Rev., 40, 229–241.
   PubMed Web of Science ®Google Scholar
• Samuelsson, B., Dahlen, S. E., Lindgren, J. A., Rouzer, C. A. and Serhan, C. N. (1987). Leukotrienes and lipoxins: Structure, biosynthesis and biological effects. Science, 237, 1171–1176.
   PubMed Web of Science ®Google Scholar
• Flore, S. and Serhan, C. N. (1990). Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelet and recombinant human granulocyte macrophage colony stimulating factor-primed neutrophils. J. Exp. Med., 172, 1451–1458.
   PubMed Web of Science ®Google Scholar
• Serhan, C. N. and Sheppard, K. A. (1990). Lipoxin formation during human neutrophil-platelet interactions: Evidence for the transformation of leukotriene A4 by platelet lipoxygenase in vitro, J. Clin. Invest., 85, 772–780.
   PubMed Web of Science ®Google Scholar
• Tornhamre, S., Gigou, A., Edenius, C., Lellouche, J. P. and Lindgren, J. A. (1992). Conversion of 5,6-dihydrxyeicosatetraenoic acids-A novel pathway for lipoxin formation by human platelets. FEBS Lett., 304, 78–82.
   PubMed Web of Science ®Google Scholar
• Edenius, C., Tornhamre, S. and Lindgren, J. A. (1994). Stimulation of lipoxin synthesis formed 12-hydroperoxyeicosatetraenoic acid in activated human platelets. Biochem. Biophys. Acta., 1210, 361–367.
   PubMed Web of Science ®Google Scholar
• Yamamoto, S. (1991). Enzymatic lipid peroxidation: Reactions of mammalian lipoxygenases. Free Rad. Biol. Med., 10, 149–159.
   PubMed Web of Science ®Google Scholar
• Kenivo, A. L., Nekrasv, A. S., Lankin, V. Z., Kholodov, A. V., Vikhert, A. M. and Popov, G. K. (1989). Lipoxin B as an enhancing factor of spontaneous platelet aggregation in whole human blood. Byull. Eksp. Biol. Med., 18, 26–28.
   Google Scholar
• Lefer, A. M., Gregory, L. S., Leffer, D. J., Brezinski, M. E., Nicolaou, K. C., Veale, C. A., Abe, Y. and Bryan, S. J. (1988). Lipoxin A4 and B4: Comparison of eicosanoids having bronchoconstriction and vasodilator activity. Proc. Natl. Acad. Sci., 85, 8340–8344.
   PubMed Web of Science ®Google Scholar
• Bratt, J., Lerner, B., Ringertz, B. and Palmblad, J. (1994). Lipoxin A4 induces neutrophil dependent cytotoxicity for human endothelial cells. Scand. J. Immunol., 39, 351–354.
   PubMed Web of Science ®Google Scholar
• Benveniste, J., Henson, P. M. and Cochrane, C. G. (1972). Leukocyte-dependent histamine release from rabbit platelets: The role of IgE, basophils and a platelet-activating factor. J. Exp. Med., 136, 1356–1377.
   PubMed Web of Science ®Google Scholar
• Benveniste, J. and Chingnard, M. (1985). A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases? Circulation, 72, 713–717.
   PubMed Web of Science ®Google Scholar
• Oda, M., Satouchi, K., Yasunaga, K. and Saito, K. (1986). Polymorphonuclear leukocyte-platelet interactions: acetyl ether phosphocholine-induced platelet activation under stimulation with chemotactic peptide. J. Biochem., 100, 1117–1123.
   PubMed Web of Science ®Google Scholar
• Coeffier, E., Joseph, D., Prevost, M. C. and Vargaftig, B. B. (1987). Platelet-leukocyte interactions: Activation of rabbit platelets by FMLP-stimulated neutrophils. Brit. J. Pharmacol., 92, 393–406.
   PubMed Web of Science ®Google Scholar
• Coeffier, E., Delautier, D., Le Couedic, J-P, Chignard, M., Denzot, Y. and Benveniste, J. (1990). Cooperation between platelets and neutrophils for PAF-acether (platelet-activating factor) formation. J. Leukocyte. Biol., 47, 234–243.
   PubMed Web of Science ®Google Scholar
• Renesto, F., Kadiri, C. and Chignard, M. (1992). Combined activation of platelets by cathepsin G and platelet activating factor, two neutrophil derived agonists. Brit. J. Haematol, 80, 205–213.
   PubMed Web of Science ®Google Scholar
• Zhou, W., Javors, M. A. and Olson, M. S. (1992). Platelet-activating factor as an intracellular signal in neutrophil-dependent platelet activation. J. Immunol., 149, 1763–1769.
   PubMed Web of Science ®Google Scholar
• Hirafuji, M. and Shinoda, H. (1991). Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro. Brit. J. Pharmacol., 103, 1333–1338.
   PubMed Web of Science ®Google Scholar
• Damiano, V. V., Kucich, U., Murer, E., Laudenslager, N. and Weinbaum, G. (1988). Ultrastructural quantitation of peroxidase- and elastase-containing granules in human neutrophils. Am. J. Pathol., 131, 234–245.
   Web of Science ®Google Scholar
• Campbell, E. J., Silveman, E. K. and Campbell, M. A. (1989). Elastase and cathepsin G of human monocytes. Quantification. of cellular content, release in response to stimuli and heterogeneity in elastase-mediated proteolytic activity. J. Immunol., 143, 2961–2968.
   PubMed Web of Science ®Google Scholar
• Halloren, R. and Venge, P. (1976). Cationic proteins of human granulocytes: effects on human platelet aggregation and serotonin release. Inflammation, 1, 359–370.
   PubMedGoogle Scholar
• Bykowska, K., Kaczanowska, J., Karpowicz, M., Stachurska, J. and Opec, M. (1983). Effect of neutral proteases from blood leukocytes on human platelets. Thromb. Haemost., 50, 768–772.
   PubMed Web of Science ®Google Scholar
• Chignard, M., Selak, M. A. and Smith, J. B. (1986). Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin). Proc. Natl. Acad. Sci., 83, 8609–8613.
   PubMed Web of Science ®Google Scholar
• Selak, M. A. (1994). Cathepsin G and thrombin: evidence for two different platelet receptors. Biochem. J., 297, 269–275.
   PubMed Web of Science ®Google Scholar
• Selak, M. A., Chignard, M. and Smith, J. B. (1988). Cathepsin G is a strong platelet agonist released by neutrophils. Biochem. J. 251, 293–299.
   PubMed Web of Science ®Google Scholar
• Molino, M., Di Lallo, M., De Gaetano, G. and Cerletti, C. (1992). Intracellular Ca + + rise in human platelets induced by polymorphonuclear-leukocyte-derived cathepsin G. Biochem. J., 288, 741–745.
   PubMed Web of Science ®Google Scholar
• Molino, M., Blanchard, N., Belmonte, E., Tarver, A. P., Abrams, C., Hoxie, J. A., Cereletti, C. and Brass, L. F. (1994). Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J. Biol. Chem., 270, 11168–11175.
   Web of Science ®Google Scholar
• LaRosa, C. A., Rohrer, M. J., Benoit, S. E., Rodino, L. J., Barnard, M. R. and Michelson, A. D. (1994). Human neutrophil cathepsin G is a potent platelet activator. J. Vas. Surg., 19, 306–319.
   PubMed Web of Science ®Google Scholar
• Brower, M. S., Levine, R. I. and Garry, K. (1985). Human neutrophil elastase modulate platelet function by limited proteolysis of membrane glycoproteins. J. Clin. Invest., 75, 657–666.
   PubMed Web of Science ®Google Scholar
• Wicki, A. N. and Clemetson, K. J. (1985). Structure and function of platelet membrane glycoproteins lb and V: Effects of leukocyte elastase and other proteases on platelet response to Von Willebrand factor and thrombin. Eur. J. Biochem., 153, 1–11.
   PubMedGoogle Scholar
• Kornecki, E., Ehrlick, H., De Mars, D. and Lenox, R. H. (1986). Exposure of fibrinogen receptors inhuman platelets by proteolysis with elastase. J. Clin. Invest., 77, 750–756.
   PubMed Web of Science ®Google Scholar
• Selak, M. A. (1992). Neutrophil elastase potentiates cathepsin G-induced platelet activation. Thromb. Haemostasis., 68, 570–576.
   PubMed Web of Science ®Google Scholar
• Aziz, K. A., Cawley, J. C., Kamiguti, A. S. and Zuzel, M. (1995). Degradation of platelet glycoprotein Ib by elastase release from primed neutrophils. Brit. J. Haematol., 91, 46–54.
   PubMed Web of Science ®Google Scholar
• Renesto, P., Halbawachs-Mecarelli, L., Nusbaum, P, Lesavre, P. and Chingard, M. (1994). Proteinase 3. A neutrophil proteinase with activity on platelets. J. Immunol., 152, 4612–4617.
   PubMed Web of Science ®Google Scholar
• Renesto, P. and Chingard, M. (1995). Neutrophil-mediated platelet activation: A key role for serine proteinases. Gen. Pharmacol., 26, 905–910.
   PubMedGoogle Scholar
• Borregaard, N., Lollike, K., Kjeldsen, L., Senoelov, H., Bastholm, L., Nielsen, M. and Bainton, D. F. (1993). Human neutrophil granules and secretory vesicles. Eur. J. Haematol, 51, 187–198.
   PubMed Web of Science ®Google Scholar
• Leveugle, B., Mazurier, J., Legrand, D., Mazurier, C., Montreuil, J. and Spik, G. (1993). Lactotransferrin binding to its platelet receptor inhibits platelet aggregation. Eur. J. Biochem., 213, 1205–1211.
   PubMedGoogle Scholar
• Mazoyer, E., Levy-Toledano, S., Rendu, F., Hermant, L., Lu., Fiat, A. M., Jolles, P. and Caen, J. (1990). KRDS, a new peptide derived from human lactotranferrin inhibits platelet aggregation and release reaction. Eur. J. Biochem., 194, 43–49.
   PubMedGoogle Scholar
• Qian, Z-Y., Jolles, P, Migliore-Samour, D. and Fiat, A-M. (1995). Isolation and characterization of sheep lactoferrin, an inhibitor of platelet aggregation and comparison with human lactoferrin. Biochem. Biophys. Acta., 1243, 25–32.
   PubMed Web of Science ®Google Scholar
• Salvemini, D., de Nucci, G., Sneddon, J. M. and Vane, J. R. (1989). Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc. Natl. Acad. Sci., 86, 6328–6332.
   PubMed Web of Science ®Google Scholar
• Schmidt, H. H. H., Seifert, R. and Bohme, E. (1989). Formation and release of nitric oxide from human neutrophil and HL-60 cells induced by chemotactic peptide, platelet activating factor and leukotriene. FEBS. Lett., 244, 357–360.
   PubMed Web of Science ®Google Scholar
• Strum, R. J., Holloway, D. A., Hardysh, B., Grimes, D., Weichman, B. M. and Rimele, T. J. (1990). Isolation and chemical characterization of neutrophil-derived relaxing factor. In.: Endothelium-Derived Relaxing Factors. Rubanyi, G. M., Cedar Knolls, N. J. and Vanhoutte, P. M. (eds) Basel Karger, 221–227.
   Google Scholar
• Moncada, S., Palmer, R. M. J. and Higgs, E. A. (1991). Nitric oxide: Pathophysiology and pharmacology. Pharmacol. Rev., 43, 109–142.
   PubMed Web of Science ®Google Scholar
• Bryant, J. L., Mehta, P, Von der Porten, A. and Mehta, J. L. (1992). Co-purification of 130 KD nitric oxide synthase and a 22 KD link protein from human neutrophils. Biochem. Biopliys. Res. Commun., 189, 558–564.
   PubMed Web of Science ®Google Scholar
• McCall, T., Palmer, R. M. J. and Moncada, S. (1991). Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur. J. Immunol., 21, 2523–2527.
   PubMed Web of Science ®Google Scholar
• Dikshit, M., Kumari, R. and Srimal, R. C. (1993). Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils. J. Pharmacol. Exp. Ther., 265, 1269–1373.
   Web of Science ®Google Scholar
• Kumari, R., Seth, P, Dikshit, M. and Srimal, R. C. (1993). Augmentation in nitric oxide release from polymorphonuclear leukocytes following thrombosis. Endothelium, 1, s81.
   Google Scholar
• Strum, R. J., Holloway, D. A., Hardysh, B., Grimes, D., Weichman, B. M. and Rimele, T. J. (1989). Potential regulatory role of inflammatory cells on local vascular smooth muscle tone. Agents Action, 27, 414–417.
   PubMedGoogle Scholar
• Faint, R. W., Mackie, I. J. and Machin, S. J. (1991). Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro. Brit. J. Haematol, 77, 539–545.
   PubMed Web of Science ®Google Scholar
• Pearson, J. D., Carleton, J. S. and Gordon, J. L. (1980). Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth muscle cells in culture. Biochem. J., 190, 412–429.
   Web of Science ®Google Scholar
• Smith, G. P. and Peters, T. J. (1981). Subcellular localization and properties of adenosine diphosphatase activity in human polymorphonuclear leukocytes. Bichim. Biophys. Acta., 673, 234–242.
   PubMed Web of Science ®Google Scholar
• Coade, S. B. and Pearson, J. D. (1989). Metabolism of adenine nucleotides in human blood. Circ. Res., 65, 531–537.
   PubMed Web of Science ®Google Scholar
• Zatta, A., Pandolfo, L., Caparrotta, L., Prosdocimi, M., Dejana, E. and Del Maschio, A. (1993). Platelet aggregation induced by the endoperoxide analogue U46619 is inhibited by polymorphonuclear leukocyte ADPase activity. Arteriosclerosis Thrombosis., 13, 696–701.
   PubMedGoogle Scholar
• Villa, S., Rotilio, D., Donati, M. B. and de Gaetano, G. (1981). Human blood leukocytes in vitro generate an inhibitor of platelet aggregation. Thromb. Res., 24, 485–487.
   PubMed Web of Science ®Google Scholar
• Kadota, K., Yui, Y., Hattori, R., Uchizumu, H. and Kawai, R. (1991). A new relaxing factor in supernatant of incubated rat peritoneal neutrophils. Amer. J. Physiol, 260, H967–H972.
   PubMed Web of Science ®Google Scholar
• Sessa, W. C. and Mullane, K. M. (1990). Release of a neutrophil-derived vasoconstrictor agent which augments platelet-induced contractions of blood vessels in vitro. Brit. J. Pharmacol., 99, 553–559.
   PubMed Web of Science ®Google Scholar
• Liu, J. J., Chen, J. R., Wiley, J., Johnston, C. I. and Buxton, B. F. (1993). Inhibition by a stable factor derived from neutrophils of endothelium-dependent relaxation in rat aorta. Amer. J. Physiol, 265 (Heart Circ. Physiol., 34), H1454–%H1459.
   PubMed Web of Science ®Google Scholar
• Liu, J. J., Chen, J. R., Bradley, C. J., Xie, B., Johnston, C. I. and Buxton, B. F. (1994). Autologous neutrophil derived supernatant inhibit endothelium dependent relaxation in human coronary bypass graft. Cardiovasc. Res., 28, 1353–1359.
   PubMed Web of Science ®Google Scholar
• Liu, J. J., Chen, J. R., Bradley, C. J., Johnston, C. I. and Buxton, B. F. (1995). Induction of Ca + + signaling and possible exocytosis in endothelial cells by a stable leukocyte-derived factor. Biochem. Biophys. Res. Commun., 206, 146–152.
   PubMed Web of Science ®Google Scholar
• Liu, J. J., Xie, B., Smith, I. L., Johnston, C. I. and Buxton, B. F. (1994). A stable leukocyte-derived factor inhibits platelet aggregation. Biochem. Biophys. Res. Commun., 201, 878–882.
   PubMed Web of Science ®Google Scholar
• Kumari, R., Seth, P. and Dikshit, M. (1996). Study on an antiaggregatory factor present in rat circulating neutrophil supernatant, Ind. J. Pharmacol, 28, 41.
   Google Scholar